Canlyniadau Chwilio - Jayachandran, Priya

Clinical Pharmacokinetics of Oral Sodium Selenite and Dosing Implications in the Treatment of Patients with Metastatic Cancer gan Jayachandran, Priya, Knox, Susan J., Garcia-Cremades, Maria, Savić, Radojka M.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

A Mechanistic In Vivo/Ex Vivo Pharmacokinetic‐Pharmacodynamic Model of Tenofovir for HIV Prevention gan Jayachandran, Priya, Garcia-Cremades, Maria, Vučićević, Katarina, Bumpus, Namandjé N., Anton, Peter, Hendrix, Craig, Savić, Radojka

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Gold nanoparticles decorated reduced graphene oxide nanolabel for voltammetric immunosensing gan Vargis, Vidhu Sara, Jayachandran Priya, Chandhana, Surendran, Harsha, Punathil Vasu, Suneesh, Nair, Bipin, Thekkedath Gopalakrishnan, Satheesh Babu

Cael y testun llawn Cael y testun llawn Cael y testun llawn

fdrci: FDR confidence interval selection and adjustment for large-scale hypothesis testing gan Millstein, Joshua, Battaglin, Francesca, Arai, Hiroyuki, Zhang, Wu, Jayachandran, Priya, Soni, Shivani, Parikh, Aparna R, Mancao, Christoph, Lenz, Heinz-Josef

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Clinical Significance of Circulating Tumor Cell Induced Epithelial-Mesenchymal Transition in Patients with Metastatic Colorectal Cancer by Single-Cell RNA-Sequencing gan Kozuka, Masahiro, Battaglin, Francesca, Jayachandran, Priya, Wang, Jingyuan, Arai, Hiroyuki, Soni, Shivani, Zhang, Wu, Hirai, Mitsuharu, Matsusaka, Satoshi, Lenz, Heinz-Josef

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Results from a Phase 1 Study of Sodium Selenite in Combination with Palliative Radiation Therapy in Patients with Metastatic Cancer gan Knox, Susan J., Jayachandran, Priya, Keeling, Christine A., Stevens, Kathryn J., Sandhu, Navjot, Stamps-DeAnda, Stacy Leanne, Savic, Rada, Shura, Lei, Buyyounouski, Mark K., Grimes, Kevin

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Disease characterization in liquid biopsy from HER2-mutated, non-amplified metastatic breast cancer patients treated with neratinib gan Shishido, Stephanie N., Masson, Rahul, Xu, Liya, Welter, Lisa, Prabakar, Rishvanth Kaliappan, D’ Souza, Anishka, Spicer, Darcy, Kang, Irene, Jayachandran, Priya, Hicks, James, Lu, Janice, Kuhn, Peter

Cael y testun llawn Cael y testun llawn Cael y testun llawn

BRAF-mutated, Microsatellite-stable Adenocarcinoma of the Proximal Colon: An Aggressive Adenocarcinoma With Poor Survival, Mucinous Differentiation, and Adverse Morphologic Feature... gan Pai, Reetesh K., Jayachandran, Priya, Koong, Albert C., Chang, Daniel T., Kwok, Shirley, Ma, Lisa, Arber, Daniel A., Balise, Raymond R., Tubbs, Raymond R., Shadrach, Bonnie, Pai, Rish K.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Germline polymorphisms in genes maintaining the replication fork predict the efficacy of oxaliplatin and irinotecan in patients with metastatic colorectal cancer gan Arai, Hiroyuki, Xiao, Yi, Millstein, Joshua, Wang, Jingyuan, Battaglin, Francesca, Kawanishi, Natsuko, Jayachandran, Priya, Soni, Shivani, Zhang, Wu, Mancao, Christoph, Salhia, Bodour, Mumenthaler, Shannon M., Parikh, Aparna R., Lenz, Heinz-Josef

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Pharmacokinetics and Safety of 3 Months of Weekly Rifapentine and Isoniazid for Tuberculosis Prevention in Pregnant Women gan Mathad, Jyoti S, Savic, Rada, Britto, Paula, Jayachandran, Priya, Wiesner, Lubbe, Montepiedra, Grace, Norman, Jennifer, Zhang, Nan, Townley, Ellen, Chakhtoura, Nahida, Bradford, Sarah, Patil, Sandesh, Popson, Stephanie, Chipato, Tsungai, Rouzier, Vanessa, Langat, Deborah, Chalermchockcharoentkit, Amphan, Kamthunzi, Portia, Gupta, Amita, Dooley, Kelly E

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Nomogram to predict the outcomes of patients with microsatellite instability-high metastatic colorectal cancer receiving immune checkpoint inhibitors gan Pietrantonio, Filippo, Lonardi, Sara, Corti, Francesca, Infante, Gabriele, Elez, Maria Elena, Fakih, Marwan, Jayachandran, Priya, Shah, Aakash Tushar, Salati, Massimiliano, Fenocchio, Elisabetta, Salvatore, Lisa, Curigliano, Giuseppe, Cremolini, Chiara, Ambrosini, Margherita, Ros, Javier, Intini, Rossana, Nappo, Floriana, Damian, Silvia, Morano, Federica, Fucà, Giovanni, Overman, Michael, Miceli, Rosalba

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Ascites and resistance to immune checkpoint inhibition in dMMR/MSI-H metastatic colorectal and gastric cancers gan Fucà, Giovanni, Cohen, Romain, Lonardi, Sara, Shitara, Kohei, Elez, Maria Elena, Fakih, Marwan, Chao, Joseph, Klempner, Samuel J, Emmett, Matthew, Jayachandran, Priya, Bergamo, Francesca, García, Marc Díez, Mazzoli, Giacomo, Provenzano, Leonardo, Colle, Raphael, Svrcek, Magali, Ambrosini, Margherita, Randon, Giovanni, Shah, Aakash Tushar, Salati, Massimiliano, Fenocchio, Elisabetta, Salvatore, Lisa, Chida, Keigo, Kawazoe, Akihito, Conca, Veronica, Curigliano, Giuseppe, Corti, Francesca, Cremolini, Chiara, Overman, Michael, Andre, Thierry, Pietrantonio, Filippo

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Molecular characteristics and clinical outcomes of patients with Neurofibromin 1-altered metastatic colorectal cancer gan Arai, Hiroyuki, Elliott, Andrew, Millstein, Joshua, Xiu, Joanne, Ou, Fang-Shu, Innocenti, Federico, Wang, Jingyuan, Battaglin, Francesca, Jayachandran, Priya, Kawanishi, Natsuko, Soni, Shivani, Zhang, Wu, Sohal, Davendra, Goldberg, Richard M., Hall, Michael J., Scott, Aaron J, Khushman, Mohd, Hwang, Jimmy J., Lou, Emil, Weinberg, Benjamin A., Lockhart, Albert Craig, Shields, Anthony Frank, Abraham, Jim P., Magee, Daniel, Stafford, Phillip, Zhang, Jian, Venook, Alan P, Korn, W. Michael, Lenz, Heinz-Josef

Cael y testun llawn Cael y testun llawn Cael y testun llawn